Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition Ltd has informed BSE that its Board of Directors will meet on August 7, 2025 in Mumbai. The main agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The filing is made under SEBI Listing Regulations (Reg. 29(1)(a)). The company has also informed that the trading window for dealing in its equity shares will remain closed until August 9, 2025, in line with insider trading norms.
This is a routine pre-results announcement with no financial numbers disclosed yet. Shareholders should watch for the actual Q1 results post the August 7 meeting to assess the company's earnings trajectory; the closed trading window means insiders cannot trade until results are published.